Imaging software company Intelerad and Strategic Radiology are highlighting recent achievements stemming from their collaboration on increasing access to advanced imaging technology for members of Strategic Radiology’s network.
The companies said that the partnership, initiated in 2020, attained several significant milestones in 2024. One noteworthy milestone was expansion: Strategic Radiology quadrupled participation in its network in 2024 with the addition of nine new member practices to its network in 10 months.
Furthermore, coalition members’ total volume commitment tripled from fewer than 2 million annual imaging studies to more than 7 million annual studies over the course of the year, the companies said.
According to the firms, the collaboration empowers the practices in Strategic Radiology’s coalition to not only access state-of-the-art technology without compromising their autonomy but also attract and retain radiology professionals.
![A normal mammogram confirmed by three-year radiologic follow-up illustrates reader-marked regions of interest (ROIs) during (A) unaided (round 1) and (B) artificial intelligence (AI)–assisted (round 2) reading. Each colored dot represents an ROI for recall by a human reader. Readers could mark more than one ROI per case, represented by multiple dots of the same color. During AI-assisted reading, the AI system displayed three visible prompts: two with suspicion of malignancy scores of 35% (left mediolateral oblique [L MLO] and craniocaudal [L CC]) and one with a suspicion of malignancy score of 10% (right craniocaudal [R CC]), shown as polygonal overlays. Without AI, six of 10 readers (60%) marked a false-positive ROI. With AI assistance, this fell to two of 10 (20%). R MLO = right mediolateral oblique.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/07/2026-07-14-radiology-mammogram-ai-auto-bias.H0bYO8QlWs.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
